VIRAL LOAD SUPPRESSION Responsible 2017 April July Oct Jan Objectives Strategies Activities/Measurements Entities goal 2017 2017 2017 2018 V1. Increase the PROGRESS TOWARD OBJECTIVES: baseline viral suppression in the EMA overall FDOH MD-C 71% from 67% in 2015 to 80% by 2021. percentage of people living with V1.1 Provide V1.1a Develop capacity for increased Test and Treat HIV in the EMA immediate access to sites, setting a goal of one (1) new site identified and in who are virally antiretroviral therapy development every 18 months, including: (1) identifying suppressed (<200 through timely linkage potential new Test and Treat sites; (2) determining FDOH M-DC copies/mL) from to medical care, what the sites need to become and Treat”-ready; and Partners “Test 67% in 2015 to at expanding the and (3) provide technical assistance to the sites to least 80% by Test and Treat assure Test and Treat readiness and success (baseline: 1 2021. model of care. in 2016). New T&T site has been identified V1.1b At least 80% of clients identified through the FDOH M-DC and Treat” model will have received antiretroviral 60% 100% “Test and Partners therapy within the seven (7) day time period. V1.2 V1.2a Enhance By December support 31, 2018 (Second Year), create an FDOH-MDC for Electronic FDOH-MDC Direct Observation Therapy system for ARV and UM treatment non-compliant adherence pregnant women. PRIM clinic (FDOH-MDC initiatives). V1.2b Beginning in January 1, 2019 (Year Three), at FDOH-MDC least 75% of women using the electronic direct and UM observation therapy will be treatment compliant. PRIM clinic V1.2c By December 31, 2017 (Year One), establish a referral service between ADAP and FDOH Peer Educators and Linkage staff to target ADAP clients not FDOH-MDC achieving viral suppression, and maintain throughout ADAP following years. A new FDOH Peer Educator has joined FDOH Peer the current efforts. Training has started. Referrals Educators have restarted after previous FDOH Peer Educator moved to a new role.
VIRAL LOAD SUPPRESSION Objectives Strategies Activities/Measurements Responsible Entities 2017 goal April 2017 July 2017 Oct 2017 Jan 2018 V1. Increase the percentage of people living with HIV in the EMA who are virally suppressed (<200 copies/mL) from 67% in 2015 to at least 80% by 2021. PROGRESS TOWARD OBJECTIVES: baseline viral suppression in the EMA overall from 67% in 2015 to 80% by 2021. FDOH MD-C 71% V1.1 Provide immediate access to antiretroviral therapy through timely linkage to medical care, expanding the Test and Treat model of care. V1.1a Develop capacity for increased Test and Treat sites, setting a goal of one (1) new site identified and in development every 18 months, including: (1) identifying potential new Test and Treat sites; (2) determining what the sites need to become “Test and Treat”-ready; and (3) provide technical assistance to the sites to assure Test and Treat readiness and success (baseline: 1 in 2016). New T&T site has been identified FDOH M-DC and Partners V1.1b At least 80% of clients identified through the “Test and Treat” model will have received antiretroviral therapy within the seven (7) day time period. FDOH M-DC and Partners 60% 100% V1.2 Enhance support for FDOH-MDC treatment adherence (FDOH-MDC initiatives). V1.2a By December 31, 2018 (Second Year), create an Electronic Direct Observation Therapy system for ARV non-compliant pregnant women. FDOH-MDC and UM PRIM clinic V1.2b Beginning in January 1, 2019 (Year Three), at least 75% of women using the electronic direct observation therapy will be treatment compliant. FDOH-MDC and UM PRIM clinic V1.2c By December 31, 2017 (Year One), establish a referral service between ADAP and FDOH Peer Educators and Linkage staff to target ADAP clients not achieving viral suppression, and maintain throughout following years. A new FDOH Peer Educator has joined the current efforts. Training has started. Referrals have restarted after previous FDOH Peer Educator moved to a new role. FDOH-MDC ADAP FDOH Peer Educators